[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Polypeptide Drug Market Report 2018

February 2018 | 110 pages | ID: A163BC2A188QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Polypeptide Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Polypeptide Drug for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Polypeptide Drug market competition by top manufacturers/players, with Polypeptide Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis
  • Merck Serono
  • Ferring Pharmaceuticals
  • Ipsen PHarma Biotech
  • Lilly
  • Asahi Kasei
  • AstraZeneca
  • SciClone Pharmaceuticals
  • Takeda
  • Roche
  • Sanofi
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Injection
  • Nasal administration
  • Lung administration
  • Oral administration
  • Transdermal administration
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Immunity Regulating Medicine (Allergy Infection and Immune)
  • Digestive System Drugs (Gastrointestinal Type)
  • Bone and Connective Tissue Types (Thyroid hormones Drug)
  • Gynecologic or Obstetric Drug
  • Tumor Drug
  • Urinary System Drug
  • Metabolic Drug (Insulin and Other Hypoglycemic Agents)
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Polypeptide Drug Market Report 2018

1 POLYPEPTIDE DRUG OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug by Product Category
  1.2.1 Asia-Pacific Polypeptide Drug Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Polypeptide Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Injection
  1.2.4 Nasal administration
  1.2.5 Lung administration
  1.2.6 Oral administration
  1.2.7 Transdermal administration
1.3 Asia-Pacific Polypeptide Drug Market by Application/End Users
  1.3.1 Asia-Pacific Polypeptide Drug Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
  1.3.3 Digestive System Drugs (Gastrointestinal Type)
  1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
  1.3.5 Gynecologic or Obstetric Drug
  1.3.6 Tumor Drug
  1.3.7 Urinary System Drug
  1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Asia-Pacific Polypeptide Drug Market by Region
  1.4.1 Asia-Pacific Polypeptide Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Polypeptide Drug (2013-2025)
  1.5.1 Asia-Pacific Polypeptide Drug Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Polypeptide Drug Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC POLYPEPTIDE DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Polypeptide Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Polypeptide Drug Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Polypeptide Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Polypeptide Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Polypeptide Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Polypeptide Drug Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Polypeptide Drug (Volume) by Application
2.4 Asia-Pacific Polypeptide Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Polypeptide Drug Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Polypeptide Drug Revenue and Market Share by Region (2013-2018)

3 CHINA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Polypeptide Drug Sales and Value (2013-2018)
  3.1.1 China Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Polypeptide Drug Revenue and Growth Rate (2013-2018)
  3.1.3 China Polypeptide Drug Sales Price Trend (2013-2018)
3.2 China Polypeptide Drug Sales Volume and Market Share by Type
3.3 China Polypeptide Drug Sales Volume and Market Share by Application

4 JAPAN POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Polypeptide Drug Sales and Value (2013-2018)
  4.1.1 Japan Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Polypeptide Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Polypeptide Drug Sales Price Trend (2013-2018)
4.2 Japan Polypeptide Drug Sales Volume and Market Share by Type
4.3 Japan Polypeptide Drug Sales Volume and Market Share by Application

5 SOUTH KOREA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Polypeptide Drug Sales and Value (2013-2018)
  5.1.1 South Korea Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Polypeptide Drug Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Polypeptide Drug Sales Price Trend (2013-2018)
5.2 South Korea Polypeptide Drug Sales Volume and Market Share by Type
5.3 South Korea Polypeptide Drug Sales Volume and Market Share by Application

6 TAIWAN POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Polypeptide Drug Sales and Value (2013-2018)
  6.1.1 Taiwan Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Polypeptide Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Polypeptide Drug Sales Price Trend (2013-2018)
6.2 Taiwan Polypeptide Drug Sales Volume and Market Share by Type
6.3 Taiwan Polypeptide Drug Sales Volume and Market Share by Application

7 INDIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Polypeptide Drug Sales and Value (2013-2018)
  7.1.1 India Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Polypeptide Drug Revenue and Growth Rate (2013-2018)
  7.1.3 India Polypeptide Drug Sales Price Trend (2013-2018)
7.2 India Polypeptide Drug Sales Volume and Market Share by Type
7.3 India Polypeptide Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Polypeptide Drug Sales and Value (2013-2018)
  8.1.1 Southeast Asia Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Polypeptide Drug Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Polypeptide Drug Sales Price Trend (2013-2018)
8.2 Southeast Asia Polypeptide Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Polypeptide Drug Sales Volume and Market Share by Application

9 AUSTRALIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Polypeptide Drug Sales and Value (2013-2018)
  9.1.1 Australia Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Polypeptide Drug Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Polypeptide Drug Sales Price Trend (2013-2018)
9.2 Australia Polypeptide Drug Sales Volume and Market Share by Type
9.3 Australia Polypeptide Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC POLYPEPTIDE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Polypeptide Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Merck Serono
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Polypeptide Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Ferring Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Polypeptide Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Ipsen PHarma Biotech
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Polypeptide Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Lilly
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Polypeptide Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Asahi Kasei
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Polypeptide Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 AstraZeneca
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Polypeptide Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 SciClone Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Polypeptide Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Takeda
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Polypeptide Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Roche
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Polypeptide Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Roche Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Sanofi

11 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

11.1 Polypeptide Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Polypeptide Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Polypeptide Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC POLYPEPTIDE DRUG MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Polypeptide Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Polypeptide Drug Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Polypeptide Drug Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Polypeptide Drug Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Polypeptide Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Polypeptide Drug Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Polypeptide Drug Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Polypeptide Drug Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Polypeptide Drug Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Polypeptide Drug Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Polypeptide Drug Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Polypeptide Drug Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Polypeptide Drug
Figure Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Polypeptide Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Nasal administration Product Picture
Figure Lung administration Product Picture
Figure Oral administration Product Picture
Figure Transdermal administration Product Picture
Figure Asia-Pacific Polypeptide Drug Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Polypeptide Drug by Application in 2017
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Examples
Table Key Downstream Customer in Immunity Regulating Medicine (Allergy Infection and Immune)
Figure Digestive System Drugs (Gastrointestinal Type) Examples
Table Key Downstream Customer in Digestive System Drugs (Gastrointestinal Type)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Examples
Table Key Downstream Customer in Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure Gynecologic or Obstetric Drug Examples
Table Key Downstream Customer in Gynecologic or Obstetric Drug
Figure Tumor Drug Examples
Table Key Downstream Customer in Tumor Drug
Figure Urinary System Drug Examples
Table Key Downstream Customer in Urinary System Drug
Figure Metabolic Drug (Insulin and Other Hypoglycemic Agents) Examples
Table Key Downstream Customer in Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure Asia-Pacific Polypeptide Drug Market Size (Million USD) by Region (2013-2025)
Figure China Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Polypeptide Drug Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Polypeptide Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Polypeptide Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Polypeptide Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Polypeptide Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Polypeptide Drug Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Polypeptide Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Polypeptide Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Polypeptide Drug Revenue Share by Players
Figure 2017 Asia-Pacific Polypeptide Drug Revenue Share by Players
Table Asia-Pacific Polypeptide Drug Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Polypeptide Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Polypeptide Drug by Type (2013-2018)
Figure Asia-Pacific Polypeptide Drug Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Polypeptide Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Polypeptide Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Type (2013-2018)
Figure Asia-Pacific Polypeptide Drug Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Polypeptide Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Polypeptide Drug by Region (2013-2018)
Figure Asia-Pacific Polypeptide Drug Sales Market Share by Region in 2017
Table Asia-Pacific Polypeptide Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Polypeptide Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Region (2013-2018)
Figure Asia-Pacific Polypeptide Drug Revenue Market Share by Region in 2017
Table Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Polypeptide Drug Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Polypeptide Drug Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Polypeptide Drug Sales Market Share by Application (2013-2018)
Figure China Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure China Polypeptide Drug Sales Volume Market Share by Type in 2017
Table China Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table China Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure China Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure Japan Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Polypeptide Drug Sales Volume Market Share by Type in 2017
Table Japan Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure South Korea Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure South Korea Polypeptide Drug Sales Volume Market Share by Type in 2017
Table South Korea Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure South Korea Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure Taiwan Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Polypeptide Drug Sales Volume Market Share by Type in 2017
Table Taiwan Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure India Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure India Polypeptide Drug Sales Volume Market Share by Type in 2017
Table India Polypeptide Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure India Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Polypeptide Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Polypeptide Drug Sales Volume Market Share by Application in 2017
Figure Australia Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Polypeptide Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Polypeptide Drug Sales Volume Market Share by Type (2013-2018)
Figure Australia Polypeptide Drug Sales Volume Market Share by Type in 2017
Table Australia Polypeptide Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Polypeptide Drug Sales Volume Market Share by Application (2013-2018)
Figure Australia Polypeptide Drug Sales Volume Market Share by Application in 2017
Table Novartis Polypeptide Drug Basic Information List
Table Novartis Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Novartis Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Merck Serono Polypeptide Drug Basic Information List
Table Merck Serono Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Serono Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Merck Serono Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Merck Serono Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Ferring Pharmaceuticals Polypeptide Drug Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Ipsen PHarma Biotech Polypeptide Drug Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Lilly Polypeptide Drug Basic Information List
Table Lilly Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Lilly Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Lilly Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Lilly Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Asahi Kasei Polypeptide Drug Basic Information List
Table Asahi Kasei Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Asahi Kasei Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table AstraZeneca Polypeptide Drug Basic Information List
Table AstraZeneca Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure AstraZeneca Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table SciClone Pharmaceuticals Polypeptide Drug Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Takeda Polypeptide Drug Basic Information List
Table Takeda Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Takeda Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Takeda Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Takeda Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Roche Polypeptide Drug Basic Information List
Table Roche Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Roche Polypeptide Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Roche Polypeptide Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Sanofi Polypeptide Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2017
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Polypeptide Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Polypeptide Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Polypeptide Drug Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Polypeptide Drug Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Polypeptide Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Polypeptide Drug Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Polypeptide Drug Revenue Market Share Forecast by Region in 2025
Figure China Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Polypeptide Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Polypeptide Drug Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Polypeptide Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Polypeptide Drug Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Polypeptide Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Polypeptide Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Polypeptide Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories